Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial. Nielsen AM, Laursen MRT, Rechner LA, Krog SM, et al. Radiother Oncol 2025;207:110906.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nielsen AM, Laursen MRT, Rechner LA, Krog SM, et al. Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial. Radiother Oncol 2025;207:110906.
PMID: 40324910